Related Experiment Video

Updated: Jun 18, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Fibrogenesis in kidney transplantation: potential targets for prevention and therapy

Arjang Djamali1, Millie Samaniego

  • 1Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53793, USA.

Transplantation
|November 26, 2009
PubMed

Insights

Preventing kidney allograft fibrosis involves targeting transforming growth factor beta1. Promising preclinical therapies include bone morphogenetic protein 7 and others, but clinical trials are needed.

Area of Science:

  • Nephrology
  • Immunology
  • Regenerative Medicine

Background:

  • Kidney allograft fibrosis is a complex process involving cellular and humoral responses, often leading to organ failure.
  • Transforming growth factor beta1 (TGF-β1) activation plays a key role in mediating fibrogenesis within the kidney graft.
  • Both parenchymal and infiltrating cells contribute to the fibrotic response post-transplantation.

Purpose of the Study:

  • To review preventive and therapeutic strategies targeting kidney allograft fibrogenesis.
  • To highlight novel therapeutic agents showing promise in preclinical studies for mitigating fibrosis.
  • To emphasize the need for clinical trials to validate long-term efficacy.

Main Methods:

  • Literature review of studies on kidney allograft fibrosis.
  • Analysis of preventive measures against fibrogenesis.
  • Evaluation of therapeutic strategies targeting fibrotic pathways.

Main Results:

  • Transforming growth factor beta1 (TGF-β1) is a central mediator in kidney allograft fibrosis.
  • Preventive strategies are crucial for managing fibrotic progression.
  • Preclinical studies show promise for bone morphogenetic protein 7 (BMP-7), hepatocyte growth factor (HGF), connective tissue growth factor (CTGF), and pirfenidone.

Conclusions:

  • Targeting fibrogenesis pathways offers potential for improved kidney allograft survival.
  • Bone morphogenetic protein 7 (BMP-7), hepatocyte growth factor (HGF), connective tissue growth factor (CTGF), and pirfenidone demonstrate therapeutic potential.
  • Further clinical investigation is essential to confirm the long-term benefits of these antifibrotic therapies.

More Related Videos

Mouse Kidney Transplantation: Models of Allograft Rejection16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...